Banco Santander, S.A. Gilead Sciences, Inc. Transaction History

Banco Santander, S.A.

$8.47 Billion
Q3 2024

A detailed history of Banco Santander, S.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Banco Santander, S.A. holds 273,560 shares of GILD stock, worth $24.7 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

273,560

Previous 339,828 19.5%

Holding current value

$24.7 Million

Previous $23.3 Million 1.66%

% of portfolio

0.27%

Previous 0.29%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $4.41 Million - $5.57 Million	-66,268 Reduced 19.5%	273,560 $22.9 Million
Q2 2024 Jul 29, 2024	BUY	$63.15 - $72.88 $7.82 Million - $9.02 Million	123,756 Added 57.28%	339,828 $23.3 Million
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $15.5 Million - $18.9 Million	216,072 New	216,072 $15.8 Million
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $190,414 - $216,941	2,463 New	2,463 $204,000
Q2 2022 Jul 28, 2022	SELL	$57.72 - $65.01 $1.22 Million - $1.38 Million	-21,213 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$57.92 - $72.58 $328,116 - $411,165	5,665 Added 36.44%	21,213 $1.26 Million
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $79,672 - $90,429	1,228 Added 8.58%	15,548 $1.13 Million
Q3 2021 Nov 08, 2021	SELL	$67.69 - $73.03 $91,246 - $98,444	-1,348 Reduced 8.6%	14,320 $1 Million
Q2 2021 Jul 29, 2021	BUY	$63.47 - $69.35 $994,447 - $1.09 Million	15,668 New	15,668 $1.08 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $526,731 - $600,185	-9,298 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$62.1 - $78.08 $405,326 - $509,628	-6,527 Reduced 41.24%	9,298 $588,000
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $88.9 Million - $103 Million	-1,228,415 Reduced 98.73%	15,825 $1.22 Million
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $77 Million - $98.6 Million	1,228,709 Added 7911.33%	1,244,240 $93 Million
Q4 2019 Feb 07, 2020	SELL	$61.62 - $67.78 $105,123 - $115,632	-1,706 Reduced 9.9%	15,531 $1.01 Million
Q3 2019 Nov 06, 2019	SELL	$62.51 - $69.0 $57.2 Million - $63.1 Million	-914,982 Reduced 98.15%	17,237 $1.09 Million
Q2 2019 Aug 07, 2019	BUY	$61.87 - $69.38 $56.5 Million - $63.4 Million	913,442 Added 4864.69%	932,219 $63 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $554,766 - $621,483	8,872 Added 89.57%	18,777 $1.22 Million
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $95,955 - $125,215	1,585 Added 19.05%	9,905 $619,000
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $514,142 - $569,249	-7,213 Reduced 46.44%	8,320 $643,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $99,331 - $115,866	-1,531 Reduced 8.97%	15,533 $1.1 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $1.16 Million - $1.41 Million	-15,904 Reduced 48.24%	17,064 $1.29 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $201,923 - $237,029	-2,838 Reduced 7.93%	32,968 $2.36 Million
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $29,997 - $35,555	-416 Reduced 1.15%	35,806 $2.9 Million
Q2 2017 Aug 11, 2017	BUY	N/A	36,222	36,222 $2.57 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.

Account

Banco Santander, S.A. Gilead Sciences, Inc. Transaction History